China Resources Pharmaceutical Group (FRA:640) Net Income (Continuing Operations) : €1,085 Mil (TTM As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is China Resources Pharmaceutical Group Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. China Resources Pharmaceutical Group's Net Income (Continuing Operations) for the six months ended in Dec. 2024 was €375 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2024 was €1,085 Mil.

China Resources Pharmaceutical Group Net Income (Continuing Operations) Historical Data

The historical data trend for China Resources Pharmaceutical Group's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Pharmaceutical Group Net Income (Continuing Operations) Chart

China Resources Pharmaceutical Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income (Continuing Operations)

Get a 7-Day Free Trial

563.96

754.98

901.51

998.53

1,102.24

China Resources Pharmaceutical Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Income (Continuing Operations)	Get a 7-Day Free Trial															303.78	648.18	352.64	709.50	375.50

China Resources Pharmaceutical Group Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1,085 Mil.

China Resources Pharmaceutical Group (FRA:640) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

China Resources Pharmaceutical Group Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of China Resources Pharmaceutical Group's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Pharmaceutical Group Ltd (FRA:640) » Definitions » Net Income (Continuing Operations)

Traded in Other Exchanges

03320:Hong Kong

Address

26 Harbour Road, Room 4104-05, 41st Floor, China Resources Building, Wanchai, HKG

Website

https://www.crpharm.com

China Resources Pharmaceutical is the third-largest medical distributor in China by revenue. It is an integrated pharmaceutical company specializing in research and development, manufacturing, medical distribution, and retail pharmacies. As of 2024, the medical distribution business accounts for 82.8% of its total revenue. CR Pharma's manufacturing business, 18.0% of total revenue, has subsidiaries with a strong presence in traditional Chinese medicine and consumer healthcare.

China Resources Pharmaceutical Group Headlines

No Headlines